# Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in China

> **NCT03646591** · — · COMPLETED · sponsor: **Ruijin Hospital** · enrollment: 10 (actual)

## Conditions studied

- Chemotherapy Effect

## Interventions

- **DRUG:** Chemotherapy

## Key facts

- **NCT ID:** NCT03646591
- **Lead sponsor:** Ruijin Hospital
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2017-11-15
- **Primary completion:** 2018-08-20
- **Final completion:** 2018-08-20
- **Target enrollment:** 10 (ACTUAL)
- **Last updated:** 2020-11-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03646591

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03646591, "Feasibility and Safety of Neoadjuvant Chemotherapy (FLOT ) for Gastric Cancer Patients in China". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03646591. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*